SL
Sabella Lauren M
Directeur Commercial
OtherF
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Sabella Lauren M, Directeur Commercial. Officer active across 2 companies, notably Acorda Therapeutics INC. In total, 11 filings have been published. History available since 3 September 2021. The latest transaction was disclosed on 27 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
16,407 shares@ US$5.1037.1% of flowCommon Stock, $.01 Par ValueSEC:0000950170-25-047092:0
722 shares@ US$3.091.0% of flowCommon Stock, $0.01 Par ValueSEC:0000950170-24-084407:0
129,000 shares0Common Stock, $.01 Par ValueSEC:0000950170-24-062065:0
17,084 shares@ US$4.6334.7% of flowCommon Stock, $.01 Par ValueSEC:0000950170-24-038816:0
711 shares@ US$3.090.9% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-24-002740:0
23,250 shares0Common Stock, $.01 Par ValueSEC:0001209191-23-032730:0
210,000 shares0Restricted Stock UnitSEC:0001209191-23-032031:0
14,184 shares@ US$4.2326.3% of flowCommon Stock,$.01 par valueSEC:0001209191-23-029518:0
1,511 shares@ US$0.3985.1% of flowCommon StockSEC:0001209191-22-048948:0
1,511 shares@ US$4.3850.0% of flowCommon StockSEC:0001209191-21-055101:0
1,511 shares@ US$4.3847.4% of flowCommon StockSEC:0001209191-21-055101
About Sabella Lauren M
Sabella Lauren M is the Chief Commercial Officer at ACORDA THERAPEUTICS INC. She oversees the company's commercial operations, including sales and business development. Lauren plays a key role in developing commercial strategies that drive growth and market expansion. Her experience in the pharmaceutical sector enables her to effectively lead commercial initiatives.